-
Posted by
Two Blokes April 24, 2025 -
Filed in
Stock
-
15 views
Upgraded Huron to 'Buy' due to strong free cash-flow growth, attractive valuation, and accelerating bullish trend, despite previous concerns over debt-fueled buybacks. Healthcare segment drives growth with 18% RBR increase in Q4 2024 and improved operating profit margins, boosting overall profitability. Low capital requirements and high ROC allow HURN to reinvest cash flow effectively, supporting share price and enabling acquisitions.
